Compare Stocks: BJDX, ICU, TMDIF, and IRIX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BJDX Bluejay Diagnostics	$0.90 -1.0%	$1.34	$0.83 ▼ $16.68	$4.02M	0.89	6.14 million shs	11.27 million shs
ICU SeaStar Medical	$3.09 -0.3%	$3.71	$2.07 ▼ $12.50	$13.62M	-1.05	74,487 shs	18,291 shs
IRIX IRIDEX	$0.71 -0.8%	$0.94	$0.70 ▼ $1.65	$12.41M	0.66	108,816 shs	98,829 shs
TMDIF Titan Medical	$0.12 +0.2%	$0.15	$0.03 ▼ $1.00	$14.11M	1.26	74,785 shs	79,136 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BJDX Bluejay Diagnostics	-1.04%	-1.20%	+2.44%	-57.94%	-83.58%
ICU SeaStar Medical	-0.32%	-7.76%	-4.92%	-16.71%	-63.55%
IRIX IRIDEX	-0.81%	-6.56%	-18.32%	-32.71%	-45.65%
TMDIF Titan Medical	+0.73%	-7.29%	-8.25%	-33.30%	-60.93%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BJDX Bluejay Diagnostics	$0.90 -1.0%	$1.34	$0.83 ▼ $16.68	$4.02M	0.89	6.14 million shs	11.27 million shs
ICU SeaStar Medical	$3.09 -0.3%	$3.71	$2.07 ▼ $12.50	$13.62M	-1.05	74,487 shs	18,291 shs
IRIX IRIDEX	$0.71 -0.8%	$0.94	$0.70 ▼ $1.65	$12.41M	0.66	108,816 shs	98,829 shs
TMDIF Titan Medical	$0.12 +0.2%	$0.15	$0.03 ▼ $1.00	$14.11M	1.26	74,785 shs	79,136 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BJDX Bluejay Diagnostics	-1.04%	-1.20%	+2.44%	-57.94%	-83.58%
ICU SeaStar Medical	-0.32%	-7.76%	-4.92%	-16.71%	-63.55%
IRIX IRIDEX	-0.81%	-6.56%	-18.32%	-32.71%	-45.65%
TMDIF Titan Medical	+0.73%	-7.29%	-8.25%	-33.30%	-60.93%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BJDX Bluejay Diagnostics	1.00	Sell	N/A	N/A
ICU SeaStar Medical	2.00	Hold	$8.00	158.90% Upside
IRIX IRIDEX	2.00	Hold	$3.00	324.63% Upside
TMDIF Titan Medical	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest BJDX, ICU, TMDIF, and IRIX Analyst Ratings

Date	Company	Brokerage	Action	Rating
8/21/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/6/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/17/2026	ICU SeaStar Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/1/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/24/2026	BJDX Bluejay Diagnostics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/16/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
6/2/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 8/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BJDX Bluejay Diagnostics	N/A	N/A	N/A	N/A	$2.11 per share	N/A
ICU SeaStar Medical	$1.23M	11.08	N/A	N/A	$0.97 per share	3.19
IRIX IRIDEX	$52.67M	0.24	N/A	N/A	($0.13) per share	-5.43
TMDIF Titan Medical	$17.63M	0.80	$6.19 per share	0.02	$1.05 per share	0.12

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BJDX Bluejay Diagnostics	-$6.85M	-$7.11	N/A	N/A	N/A	N/A	-125.00%	-99.79%	11/13/2026 (Estimated)
ICU SeaStar Medical	-$12.15M	-$3.91	N/A	N/A	N/A	-795.51%	-162.75%	-109.89%	11/12/2026 (Estimated)
IRIX IRIDEX	-$4.44M	-$0.20	N/A	N/A	N/A	-6.88%	N/A	-12.55%	11/17/2026 (Estimated)
TMDIF Titan Medical	$6.95M	$0.05	N/A	N/A	N/A	N/A	-82.31%	-51.47%	N/A

Latest BJDX, ICU, TMDIF, and IRIX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/18/2026	Q2 2026	IRIX IRIDEX	-$0.01	-$0.07	-$0.06	-$0.07	$13.59 million	$12.57 million
8/12/2026	Q2 2026	BJDX Bluejay Diagnostics	-$3,520.00	-$1.12	+$3,518.88	-$1.12	N/A	N/A
8/12/2026	Q2 2026	ICU SeaStar Medical	-$0.97	-$0.91	+$0.06	-$0.91	$0.49 million	$0.62 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BJDX Bluejay Diagnostics	N/A	N/A	N/A	N/A	N/A
ICU SeaStar Medical	N/A	N/A	N/A	N/A	N/A
IRIX IRIDEX	N/A	N/A	N/A	N/A	N/A
TMDIF Titan Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BJDX Bluejay Diagnostics	N/A	4.64	4.64
ICU SeaStar Medical	N/A	1.89	1.87
IRIX IRIDEX	N/A	1.82	1.08
TMDIF Titan Medical	N/A	3.73	3.73

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BJDX Bluejay Diagnostics	18.47%
ICU SeaStar Medical	1.69%
IRIX IRIDEX	20.10%
TMDIF Titan Medical	0.03%

Insider Ownership

Company	Insider Ownership
BJDX Bluejay Diagnostics	6.10%
ICU SeaStar Medical	0.70%
IRIX IRIDEX	8.60%
TMDIF Titan Medical	0.02%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BJDX Bluejay Diagnostics	9	4.47 million	4.20 million	Not Optionable
ICU SeaStar Medical	2	4.41 million	4.38 million	Not Optionable
IRIX IRIDEX	120	17.57 million	16.05 million	Optionable
TMDIF Titan Medical	50	114.04 million	4.56 million	Not Optionable

BJDX, ICU, TMDIF, and IRIX Headlines

Recent News About These Companies

Titan Medical Group Launches Titan Workforce Solutions: Launches to Transform Healthcare Staffing

April 29, 2025 | businesswire.com

Titan Nurse Staffing, LLC and Titan Medical Group, LLC Announce Merger to Streamline Healthcare Staffing Services

April 29, 2025 | businesswire.com

Titan MRI acquires High Field MRI, expanding Titan MRI's service to North Central Florida

December 3, 2024 | msn.com

Attack on Titan movie release date, trailer, changes, and everything else we know about The Last Attack

November 6, 2024 | gamesradar.comG

Conavi Medical Corp. (formerly “Titan Medical Inc.”) Completes Business Combination

October 11, 2024 | globenewswire.com

Titan Announces the Closing of Conavi's Private Placement of Subscription Receipts and Provides Update on the Transaction

October 8, 2024 | globenewswire.com

Titan Announces Resignations of Directors

October 2, 2024 | globenewswire.com

Titan Reports Voting Results from 2023 Annual General and Special Meeting

September 30, 2024 | globenewswire.com

Titan Medical begins process to move to the TSX Venture Exchange

September 30, 2024 | globenewswire.com

Conavi Medical Shareholders Approve the Proposed Amalgamation Between Titan and Conavi

September 26, 2024 | globenewswire.com

Proxy Deadline Thursday September 26, 2024

September 25, 2024 | globenewswire.com

Proxy Advisor Glass, Lewis & Co., Recommends Titan Shareholders Vote FOR the Amalgamation Between Titan and Conavi

September 19, 2024 | globenewswire.com

A key employee says the Titan sub tragedy could have been prevented

September 18, 2024 | postregister.comP

Titan Announces Conavi Medical to Present Overview at Titan Q&A Session

September 16, 2024 | globenewswire.com

Independent Proxy Advisor, Institutional Shareholder Services (“ISS”), Recommends Titan Shareholders Vote FOR the Amalgamation Between Titan and Conavi

September 16, 2024 | globenewswire.com

Titan Announces Q&A Session with Shareholders

September 9, 2024 | globenewswire.com

Titan Announces Filing of the Management Information Circular.

September 6, 2024 | globenewswire.com

Titan Medical | Morning Blend

September 3, 2024 | msn.com

Titan Medical Inc. (QTNA.SG)

August 24, 2024 | finance.yahoo.com

Titan Medical Reports Operating and Financial Results for the Second Quarter 2024

August 15, 2024 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BJDX, ICU, TMDIF, and IRIX Company Descriptions

Bluejay Diagnostics NASDAQ:BJDX

$0.90 -0.01 (-1.04%)

As of 08/28/2026 04:00 PM Eastern

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

SeaStar Medical NASDAQ:ICU

$3.09 -0.01 (-0.32%)

As of 08/28/2026 04:00 PM Eastern

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

IRIDEX NASDAQ:IRIX

$0.71 -0.01 (-0.81%)

As of 08/28/2026 04:00 PM Eastern

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Titan Medical NASDAQ:TMDIF

$0.12 +0.00 (+0.24%)

As of 08/28/2026

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BJDX, ICU, TMDIF, and IRIX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BJDX, ICU, TMDIF, and IRIX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BJDX, ICU, TMDIF, and IRIX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BJDX, ICU, TMDIF, and IRIX Company Descriptions

Bluejay Diagnostics NASDAQ:BJDX

SeaStar Medical NASDAQ:ICU

IRIDEX NASDAQ:IRIX

Titan Medical NASDAQ:TMDIF

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BJDX, ICU, TMDIF, and IRIX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BJDX, ICU, TMDIF, and IRIX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BJDX, ICU, TMDIF, and IRIX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BJDX, ICU, TMDIF, and IRIX Company Descriptions

Bluejay Diagnostics NASDAQ:BJDX

SeaStar Medical NASDAQ:ICU

IRIDEX NASDAQ:IRIX

Titan Medical NASDAQ:TMDIF

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools